SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-12-039171
Filing Date
2012-07-26
Accepted
2012-07-26 17:01:24
Documents
2
Period of Report
2012-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7431
2 POA DOCUMENT poa.txt EX-24.3_433101 3528
  Complete submission text file 0001209191-12-039171.txt   12222
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Pace Megan E (Reporting) CIK: 0001554979 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19319 | Film No.: 12988038